Brief: Ceapro Inc. Provides Corporate Update
23/04/2018 14:13
April 23 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO INC. PROVIDES CORPORATE UPDATE
* CEAPRO INC - DATA EXPECTED FROM BIOAVAILABILITY STUDY OF
COQ10-BETA GLUCAN AND RESULTS OF AVENANTHRAMIDES IN
EXERCISE-INDUCED INFLAMMATION IN Q2 2018
Source text for Eikon: ID:nGNX83dsqp
Further company coverage: CZO.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases